ProShare Advisors
MANE icon

ProShare Advisors’s Veradermics Inc MANE Stock Holding History

ProShare Advisors’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$336K Sell
2,773
-78
-3% -$8.53K ﹤0.01% 1264
2026
Q2 		$351K Buy
+2,851
New +$267K ﹤0.01% 1327

Other funds holding MANE

Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Private Capital Advisors
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Fulton Bank
Fulton Bank Lancaster, Pennsylvania $3.29B AUM 13.65% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

ProShare Advisors's MANE Position: Q3 2026 in Review

ProShare Advisors reduced its Veradermics Inc (MANE) stake by 2.7% in Q3 2026, selling an estimated $8.53K and leaving 2,773 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

ProShare Advisors first reported a position in MANE in Q2 2026 and has held it in 2 quarters since. The position peaked at $351K in Q2 2026. 26 funds tracked by Wall St. Rank hold MANE as of Q3 2026.

  • ProShare Advisors held 2,773 shares of Veradermics Inc worth $336K as of Q3 2026.
  • ProShare Advisors sold 78 Veradermics Inc shares in Q3 2026, an estimated $8.53K.
  • Veradermics Inc made up ﹤0.01% of ProShare Advisors's portfolio in Q3 2026, its #1264 holding.
  • ProShare Advisors first reported a position in Veradermics Inc in Q2 2026 and has held it in 2 quarters since.
  • ProShare Advisors's Veradermics Inc position peaked at $351K in Q2 2026.
  • 26 funds tracked by Wall St. Rank held Veradermics Inc as of Q3 2026.

Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.